Omega Healthcare Investors (OHI) Receivables - Accured (2016 - 2025)

Omega Healthcare Investors' Revenue - Other history spans 14 years, with the latest figure at $9.0 million for Q4 2025.

  • For Q4 2025, Revenue - Other rose 1112.42% year-over-year to $9.0 million; the TTM value through Dec 2025 reached $13.0 million, up 107.59%, while the annual FY2025 figure was $13.0 million, 107.59% up from the prior year.
  • Receivables - Accured for Q4 2025 was $2.4 million at Omega Healthcare Investors, up from $2.2 million in the prior quarter.
  • Across five years, Receivables - Accured topped out at $11.9 million in Q1 2021 and bottomed at $1.6 million in Q2 2024.
  • The 5-year median for Receivables - Accured is $6.8 million (2022), against an average of $6.5 million.
  • The largest annual shift saw Revenue - Other crashed 81.22% in 2021 before it skyrocketed 1112.42% in 2025.
  • A 5-year view of Revenue - Other shows it stood at $451000.0 in 2021, then crashed by 49.45% to $228000.0 in 2022, then dropped by 12.28% to $200000.0 in 2023, then surged by 270.5% to $741000.0 in 2024, then surged by 1112.42% to $9.0 million in 2025.
  • Per Business Quant, the three most recent readings for OHI's Revenue - Other are $9.0 million (Q4 2025), $2.2 million (Q3 2025), and $307000.0 (Q2 2025).